Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Postpartum Hemorrhage
and you are
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

The purpose of the study is to evaluate the safety, feasibility and applicability of a new device 'Tampostat' in the management of primary postpartum hemorrhage and compare the efficacy of 'Tampostat' in terms of arresting primary PPH with that of the conventional condom catheter.

Provided treatments

  • Device: Tampostat
  • Device: Condom catheter tamponade
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02416089. The sponsor of the trial is International Centre for Diarrhoeal Disease Research, Bangladesh and it is looking for 344 volunteers for the current phase.
Official trial title:
Tampostat: A Low-cost, Self-regulating Tamponade for Management of Postpartum Hemorrhage in Bangladesh